Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
McBride plc is a leading British-based manufacturer and supplier of private label and contract manufactured household and personal care products, serving the domestic and professional cleaning and hygiene markets across Europe, Asia-Pacific, and internationally. Founded in 1927 in Manchester by Robert McBride as a producer of textile chemicals, the company evolved into a key player in private-label detergents, cleaners, and toiletries, becoming Europe's largest maker of retailer own-brand household goods. It operates through five specialized divisions: Liquids (laundry detergents, dishwasher liquids, surface cleaners), Powders (laundry powders, water softeners), Unit Dosing (auto dishwasher tablets, laundry capsules), Aerosols (household, insecticides, personal care), and Asia Pacific (personal care and household products). With manufacturing facilities in the UK, France, Belgium, Italy, Spain, Poland, Denmark, Malaysia, and Vietnam, McBride supplies over 90% of Europe's top 50 grocery retailers, offering recyclable packaging and products under brands like Surcare, Oven Pride, and Clean N Fresh. Headquartered in Middleton, Manchester, it emphasizes efficiency, innovation, and sustainable growth, positioning itself as a vital partner for retailers and brand owners in delivering everyday value cleaning solutions.
£1.63
+£0.00 (+0.00%)
EOD Jul 3, 2026
Operating margin is thin at 7.20%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 5.2%, steady but not accelerating.
Even for strong businesses, today's 9x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
8.7x earnings, 7.1x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£935M
▲ +5.2% YoY
Net Income (TTM)
£33M
▲ +389.6% YoY
Op. Margin
7.20%
▲ +5.3pp YoY
ROIC
23.54%
▲ +17.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
£40M
▲ +4500.0% YoY
Op. Cash Flow (TTM)
£61M
▲ +777.1% YoY
Net Debt
£132M
Cash & Equiv.
£9M
3Y CAGR: +11.1%
Continue Research
At a P/E of 8.7 and a price-to-free-cash-flow of 7.1, McBride (MCB.XLON) trades below a two-stage DCF intrinsic value of about £3.72 per share, so at £1.63 the stock looks undervalued (128.0% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, McBride scores 84/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about £3.72 per share for MCB.XLON, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around £2.79. At today's £1.63, that puts the stock about 128.0% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
McBride scores 84 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a high-quality business on these measures. Recent fundamentals include a 7.2% operating margin and a 23.5% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. MCB.XLON currently trades below its estimated intrinsic value and scores 84/100 on quality (high-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.